-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
How Long Can the Rally in Canopy Growth Stock Last?
Canopy Growth stock is up 21% since Monday, but the reality of Cannabis 2.0 is likely to take the momentum out of any recovery.
Here’s How Aphria Stock Could Double in 2020
Improving fundamentals and a favorable valuation lay the groundwork for a big rally by Aphria stock over the next 12 months.
CRON Stock Could Ride the Cannabis Resurgence into a Year-Long Rally
As a high-quality pick in a resurgent cannabis sector, CRON stock could be due for big returns in calendar 2020.
Why Canopy Growth Stock Holding $20 Might Go Up in Smoke
Canopy Growth’s prospects in 2020 look much like last year’s, but growing store count and Cannabis 2.0 might help Canopy Growth stock.
Hexo Stock May Bottom Here, but It Probably Won’t
Pot stocks will rebound in 2020, but HEXO stock may not join the party, as growth trends remain pressured by competition.
Here’s Why It’s Not Too Late to Buy Canopy Growth Stock
A major bottom is in, but there’s a better way to play Canopy Growth stock than buying shares today.
Should Investors Buy Aurora Stock in 2020?
ACB stock may continue to be punished until it becomes consistently profitable and improves cash flow
Stock Market Today: Jobs Disappoint, Aurora Cannabis Stock to $1?
Six Flags cratered, the jobs report disappointed and Aurora Cannabis could have big downside. Here's what happened in the stock market today.
Could the Pain Finally Be Over for Canopy Growth Stock?
After a dismal 2019, the owners of CGC stock are hoping for sunnier days ahead. Will Canopy Growth stock come through for them?
Two Key Questions for Canopy Growth Stock in 2020
2019 was an ugly year for Canopy Growth stock. CGC can rebound in 2020 if it can capitalize on key opportunities.
Is Aphria Stock Really the ‘Best’ Canadian Pot Stock?
Aphria stock may be the best option for Canadian pot stocks, but possible suitors can't forget the challenges surrounding the entire sector.
It Doesn’t Look as If the ACB Stock Turnaround Is Coming Any Time Soon
After struggling in 2019, investors are hoping for a fresh start for Aurora stock. Here are a few things you need to know about ACB stock.
Canopy Growth Stock Looks Ready to Gain From Big Catalysts in 2020
Canopy Growth stock investors are excited about a new CEO at the helm and new Cannabis 2.0 products on the way. CGC stock looks primed for 2020.
Hexo Stock Is in a Race Against Time
Hexo stock has fallen just over 80% as it waits for Cannabis 2.0 to take root. However, after a year of overpromising, investors' patience is thin.
What Hexo Stock Needs Is Some Old-Fashioned Reaganomics
Last year was a year of reckoning for Hexo stock and the broader cannabis market. However, most of the pain may have resulted from unnecessary government inefficiencies.
